Daniel J Livorsi1,2, Rajeshwari Nair2, Andrew Dysangco3, Andrea Aylward4, Bruce Alexander1, Matthew W Smith2, Sammantha Kouba2, Eli N Perencevich1,2. 1. Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA. 2. Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. 3. Indiana University School of Medicine and the Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, USA. 4. Sioux Falls VA Health Care System, Sioux Falls, South Dakota, USA.
Abstract
BACKGROUND: In this pilot trial, we evaluated whether audit-and-feedback was a feasible strategy to improve antimicrobial prescribing in emergency departments (EDs). METHODS: We evaluated an audit-and-feedback intervention using a quasi-experimental interrupted time-series design at 2 intervention and 2 matched-control EDs; there was a 12-month baseline, 1-month implementation, and 11-month intervention period. At intervention sites, clinicians received (1) a single, one-on-one education about antimicrobial prescribing for common infections and (2) individualized feedback on total and condition-specific (uncomplicated acute respiratory infection [ARI]) antimicrobial use with peer-to-peer comparisons at baseline and every quarter. The primary outcome was the total antimicrobial-prescribing rate for all visits and was assessed using generalized linear models. In an exploratory analysis, we measured antimicrobial use for uncomplicated ARI visits and manually reviewed charts to assess guideline-concordant management for 6 common infections. RESULTS: In the baseline and intervention periods, intervention sites had 28 016 and 23 164 visits compared to 33 077 and 28 835 at control sites. We enrolled 27 of 31 (87.1%) eligible clinicians; they acknowledged receipt of 33.3% of feedback e-mails. Intervention sites compared with control sites had no absolute reduction in their total antimicrobial rate (incidence rate ratio = 0.99; 95% confidence interval, 0.98-1.01). At intervention sites, antimicrobial use for uncomplicated ARIs decreased (68.6% to 42.4%; P < .01) and guideline-concordant management improved (52.1% to 72.5%; P < .01); these improvements were not seen at control sites. CONCLUSIONS: At intervention sites, total antimicrobial use did not decrease, but an exploratory analysis showed reduced antimicrobial prescribing for viral ARIs. Future studies should identify additional targets for condition-specific feedback while exploring ways to make electronic feedback more acceptable. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.
BACKGROUND: In this pilot trial, we evaluated whether audit-and-feedback was a feasible strategy to improve antimicrobial prescribing in emergency departments (EDs). METHODS: We evaluated an audit-and-feedback intervention using a quasi-experimental interrupted time-series design at 2 intervention and 2 matched-control EDs; there was a 12-month baseline, 1-month implementation, and 11-month intervention period. At intervention sites, clinicians received (1) a single, one-on-one education about antimicrobial prescribing for common infections and (2) individualized feedback on total and condition-specific (uncomplicated acute respiratory infection [ARI]) antimicrobial use with peer-to-peer comparisons at baseline and every quarter. The primary outcome was the total antimicrobial-prescribing rate for all visits and was assessed using generalized linear models. In an exploratory analysis, we measured antimicrobial use for uncomplicated ARI visits and manually reviewed charts to assess guideline-concordant management for 6 common infections. RESULTS: In the baseline and intervention periods, intervention sites had 28 016 and 23 164 visits compared to 33 077 and 28 835 at control sites. We enrolled 27 of 31 (87.1%) eligible clinicians; they acknowledged receipt of 33.3% of feedback e-mails. Intervention sites compared with control sites had no absolute reduction in their total antimicrobial rate (incidence rate ratio = 0.99; 95% confidence interval, 0.98-1.01). At intervention sites, antimicrobial use for uncomplicated ARIs decreased (68.6% to 42.4%; P < .01) and guideline-concordant management improved (52.1% to 72.5%; P < .01); these improvements were not seen at control sites. CONCLUSIONS: At intervention sites, total antimicrobial use did not decrease, but an exploratory analysis showed reduced antimicrobial prescribing for viral ARIs. Future studies should identify additional targets for condition-specific feedback while exploring ways to make electronic feedback more acceptable. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.
Authors: Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi Journal: Clin Infect Dis Date: 2016-04-13 Impact factor: 9.079
Authors: Deanna J Buehrle; Rameez H Phulpoto; Marilyn M Wagener; Cornelius J Clancy; Brooke K Decker Journal: Antimicrob Agents Chemother Date: 2020-12-16 Impact factor: 5.191
Authors: Daniella Meeker; Jeffrey A Linder; Craig R Fox; Mark W Friedberg; Stephen D Persell; Noah J Goldstein; Tara K Knight; Joel W Hay; Jason N Doctor Journal: JAMA Date: 2016-02-09 Impact factor: 56.272
Authors: Sara E Cosgrove; Susan K Seo; Maureen K Bolon; Kent A Sepkowitz; Michael W Climo; Daniel J Diekema; Kathleen Speck; Vidhya Gunaseelan; Gary A Noskin; Loreen A Herwaldt; Edward Wong; Trish M Perl Journal: Infect Control Hosp Epidemiol Date: 2012-04 Impact factor: 3.254
Authors: Andrew M Morris; Michael S Calderwood; Scott K Fridkin; Daniel J Livorsi; Jessina C McGregor; Lona Mody; Rebekah W Moehring; Amy L Pakyz; Edward Stenehjem; Julia E Szymczak; Pranita D Tamma Journal: Infect Control Hosp Epidemiol Date: 2019-10-30 Impact factor: 6.520
Authors: Katie J Suda; Lauri A Hicks; Rebecca M Roberts; Robert J Hunkler; Linda M Matusiak; Glen T Schumock Journal: Clin Infect Dis Date: 2018-01-06 Impact factor: 20.999
Authors: James L Lowery; Bruce Alexander; Rajeshwari Nair; Brett H Heintz; Daniel J Livorsi Journal: Infect Control Hosp Epidemiol Date: 2020-12-14 Impact factor: 6.520
Authors: George F Jones; Valeria Fabre; Jeremiah Hinson; Scott Levin; Matthew Toerper; Jennifer Townsend; Sara E Cosgrove; Mustapha Saheed; Eili Y Klein Journal: Antimicrob Steward Healthc Epidemiol Date: 2021-12-23
Authors: Justin Z Chen; Holly L Hoang; Maryna Yaskina; Dima Kabbani; Karen E Doucette; Stephanie W Smith; Cecilia Lau; Jackson Stewart; Karen Zurek; Morgan Schultz; Carlos Cervera Journal: PLoS One Date: 2022-03-23 Impact factor: 3.240